Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells
Authors:
- 1 May 2010
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 298 (5) , L696-L703
Abstract
Bleomycin, a chemotherapeutic agent, can cause pulmonary fibrosis in humans and is commonly used to induce experimental pulmonary fibrosis in rodents. In cell culture, bleomycin causes single- and double-stranded DNA breaks and produces reactive oxidative species, both of which require iron (Fe2+) and O2. The mechanism of bleomycin-induced apoptosis is controversial due to its complexity. We investigated bleomycin apoptotic signaling events in primary pulmonary endothelial cells. Time course experiments revealed that bleomycin induced apoptosis within 4 h. Caspase-8, the initiator caspase for the extrinsic pathway, was activated within 2 h and preceded activation of the effector caspases-3 and -6 (4 h). Caspase-9, the initiator of the intrinsic pathway and release of cytochrome c from the mitochondria were not detected at these time points. Bleomycin induced the expression of Bcl-2 and Bcl-xL, Bcl-2 family member proteins that protect cells from the mitochondria-dependent intrinsic apoptosis. Real-time quantitative RT-PCR results demonstrated that, at 4–8 h, bleomycin induced expression of TNF and TNF receptor family genes known to induce the extrinsic apoptotic pathway. Silencing of the death receptor adaptor protein Fas-associated death domain by short interfering RNA significantly reduced bleomycin-induced apoptosis. Apoptosis was also abrogated by caspase-8 inhibition, but only slightly reduced by caspase-3 inhibition. Together, these data suggest that bleomycin initiates apoptosis via the extrinsic pathway.Keywords
This publication has 32 references indexed in Scilit:
- VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in ratsJournal of Clinical Investigation, 2009
- Executioner caspase-3 and caspase-7 are functionally distinct proteasesProceedings of the National Academy of Sciences, 2008
- Inhibitor of Differentiation 1 Promotes Endothelial Survival in a Bleomycin Model of Lung Injury in MiceThe American Journal of Pathology, 2007
- Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivityCell Research, 2006
- Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapyOncogene, 2006
- Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathwayAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathwayAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- The CD95(APO-1/Fas) DISC and beyondCell Death & Differentiation, 2003
- Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.Journal of Clinical Investigation, 1996
- Pulmonary toxicity of bleomycin.Environmental Health Perspectives, 1976